Treatment Patterns and Costs Associated with Stage IV Non-Small Cell Lung Cancer in a Mexican Population: A Chart Review.

Alatorre, Jorge Arturo; Campos-Gómez, Saúl; De la Mora, Emmanuel; Novick, Diego; Cruz, Angélica; Iglesias-Chiesa, Jimena María

Alatorre, Jorge Arturo; Campos-Gómez, Saúl; De la Mora, Emmanuel; Novick, Diego; Cruz, Angélica; Iglesias-Chiesa, Jimena María.

Afiliación

Alatorre JA; National Institute of Respiratory Diseases, Mexico City, Mexico.
Campos-Gómez S; Department of Medical Oncology, State Oncology Center, Social Security Institute of the State of Mexico and Municipalities, Mexico City, State of Mexico, Mexico.
De la Mora E; Jalisco Cancer Institute, Jalisco, Mexico.
Novick D; Eli Lilly and Company, Surrey, UK. novick_diego@lilly.com.
Cruz A; Eli Lilly and Company, Mexico City, Mexico.
Iglesias-Chiesa JM; ZEED Pharmaceutical Solutions, Mexico City, Mexico.

Pharmacoecon Open ; 4(2): 381-388, 2020 Jun.

Article en En | MEDLINE | ID: mdl-31456159

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_financiamento_saude Tipo de estudio: Clinical_trials / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Mexico Idioma: En Revista: Pharmacoecon Open Año: 2020 Tipo del documento: Article País de afiliación: México

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google